Syneos Health Podcast | Asembia's AXS25 Summit: Navigating Modern Market Access Series
The biopharmaceutical drug market is expanding at an unprecedented pace, fueled by groundbreaking innovations and the rapid adoption of new therapies. But with progress comes complexity—soaring costs, evolving regulations, and persistent access challenges. How is the industry adapting to navigate these hurdles? And what strategies are unlocking new opportunities for patients, providers, and innovators alike?
This special series of the Syneos Health Podcast, in collaboration with Asembia's ASX25 Summit, will feature interviews with key thought leaders and industry experts on the ground to explore the dynamic forces shaping the market today.
Scroll down to listen to all available episodes as we uncover key strategies, industry trends and collaborative innovations driving the future of market access and specialty pharmacy.
Learn more about our presence at the AXS25 Summit or book a meeting with our team here.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Want to be notified when new episodes are released?
Episode 1: Navigating Modern Market Access
In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad, Managing Director, Commercial Advisory, Syneos Health and Sara Rubin, Senior Vice President, Market Access Strategy at Spherico, a Syneos Health company, unpack the dynamic forces reshaping how therapies reach patients. Recorded ahead of Asembia’s AXS25 Specialty Pharmacy Summit, they dive into the impact of tariffs, the power of AI in streamlining patient support, the ripple effects of the Inflation Reduction Act and how digital transformation is changing the way manufacturers engage population health decision-makers.
Related
Looking for exclusive insight?
